Intramuscular (IM) B12 injections using hydroxocobalamin, the preferred licensed form in the UK are recommended when: Oral supplementation has failed to correct a documented deficiency The patient has difficulty adhering to daily oral regimens Serum B12 levels remain persistently low despite adequate oral dosing There is clinical evidence of neurological or haematological complications In line with BNF guidance, the standard IM regimen for confirmed deficiency without neurological involvement is a loading course of 1 mg hydroxocobalamin on alternate days for two weeks , followed by maintenance of 1 mg every three months
While this rapid evolution toward multi-agonist strategies and oral formulations promises enhanced efficacy, tolerability, and adherence, generating robust long-term safety and efficacy evidence remains imperative
Well break down exactly what sets each one apart so you can match the vendor to your research needs
STORAGE AND HANDLING Lyophilized Peptide Stability All BIONIX Research products are manufactured using lyophilization a pharmaceutical-industry freeze-drying process that creates a stable crystalline structure, removing approximately 95% of moisture from the peptide compound
PubMed laboratory research record [PMID: 16568602] PubMed record related to this compound for laboratory literature review